• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global central nervous system (CNS) stimulant drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global central nervous system (CNS) stimulant drugs market 2017 – 2021 ($ million)
o 4.2 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 6.4 Others – Market size and forecast 2022-2027
o Exhibit 38: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027
o Exhibit 48: Chart on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
o 7.4 Narcolepsy – Market size and forecast 2022-2027
o Exhibit 52: Chart on Narcolepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Narcolepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Narcolepsy – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Narcolepsy – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 56: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Azurity Pharmaceuticals Inc.
o Exhibit 111: Azurity Pharmaceuticals Inc. – Overview
o Exhibit 112: Azurity Pharmaceuticals Inc. – Product / Service
o Exhibit 113: Azurity Pharmaceuticals Inc. – Key offerings
o 12.4 Elite Pharmaceuticals Inc.
o Exhibit 114: Elite Pharmaceuticals Inc. – Overview
o Exhibit 115: Elite Pharmaceuticals Inc. – Business segments
o Exhibit 116: Elite Pharmaceuticals Inc. – Key offerings
o Exhibit 117: Elite Pharmaceuticals Inc. – Segment focus
o 12.5 Hisamitsu Pharmaceutical Co. Inc.
o Exhibit 118: Hisamitsu Pharmaceutical Co. Inc. – Overview
o Exhibit 119: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
o Exhibit 120: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
o 12.6 Ironshore
o Exhibit 121: Ironshore – Overview
o Exhibit 122: Ironshore – Product / Service
o Exhibit 123: Ironshore – Key offerings
o 12.7 Jazz Pharmaceuticals Plc
o Exhibit 124: Jazz Pharmaceuticals Plc – Overview
o Exhibit 125: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 126: Jazz Pharmaceuticals Plc – Key news
o Exhibit 127: Jazz Pharmaceuticals Plc – Key offerings
o 12.8 KemPharm Inc.
o Exhibit 128: KemPharm Inc. – Overview
o Exhibit 129: KemPharm Inc. – Product / Service
o Exhibit 130: KemPharm Inc. – Key offerings
o 12.9 Merck and Co. Inc.
o Exhibit 131: Merck and Co. Inc. – Overview
o Exhibit 132: Merck and Co. Inc. – Business segments
o Exhibit 133: Merck and Co. Inc. – Key news
o Exhibit 134: Merck and Co. Inc. – Key offerings
o Exhibit 135: Merck and Co. Inc. – Segment focus
o 12.10 Novartis AG
o Exhibit 136: Novartis AG – Overview
o Exhibit 137: Novartis AG – Business segments
o Exhibit 138: Novartis AG – Key offerings
o Exhibit 139: Novartis AG – Segment focus
o 12.11 Pfizer Inc.
o Exhibit 140: Pfizer Inc. – Overview
o Exhibit 141: Pfizer Inc. – Product / Service
o Exhibit 142: Pfizer Inc. – Key news
o Exhibit 143: Pfizer Inc. – Key offerings
o 12.12 Purdue Pharma LP
o Exhibit 144: Purdue Pharma LP – Overview
o Exhibit 145: Purdue Pharma LP – Product / Service
o Exhibit 146: Purdue Pharma LP – Key offerings
o 12.13 Sanofi SA
o Exhibit 147: Sanofi SA – Overview
o Exhibit 148: Sanofi SA – Business segments
o Exhibit 149: Sanofi SA – Key news
o Exhibit 150: Sanofi SA – Key offerings
o Exhibit 151: Sanofi SA – Segment focus
o 12.14 Takeda Pharmaceutical Co. Ltd.
o Exhibit 152: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 153: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 154: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 156: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 157: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.16 Tris Pharma Inc.
o Exhibit 161: Tris Pharma Inc. – Overview
o Exhibit 162: Tris Pharma Inc. – Product / Service
o Exhibit 163: Tris Pharma Inc. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 164: Viatris Inc. – Overview
o Exhibit 165: Viatris Inc. – Business segments
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global central nervous system (CNS) stimulant drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Application – Market share 2022-2027 (%)
Exhibits45: Data Table on Application – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Narcolepsy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Narcolepsy – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Narcolepsy – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Narcolepsy – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Azurity Pharmaceuticals Inc. – Overview
Exhibits112: Azurity Pharmaceuticals Inc. – Product / Service
Exhibits113: Azurity Pharmaceuticals Inc. – Key offerings
Exhibits114: Elite Pharmaceuticals Inc. – Overview
Exhibits115: Elite Pharmaceuticals Inc. – Business segments
Exhibits116: Elite Pharmaceuticals Inc. – Key offerings
Exhibits117: Elite Pharmaceuticals Inc. – Segment focus
Exhibits118: Hisamitsu Pharmaceutical Co. Inc. – Overview
Exhibits119: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
Exhibits120: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
Exhibits121: Ironshore – Overview
Exhibits122: Ironshore – Product / Service
Exhibits123: Ironshore – Key offerings
Exhibits124: Jazz Pharmaceuticals Plc – Overview
Exhibits125: Jazz Pharmaceuticals Plc – Product / Service
Exhibits126: Jazz Pharmaceuticals Plc – Key news
Exhibits127: Jazz Pharmaceuticals Plc – Key offerings
Exhibits128: KemPharm Inc. – Overview
Exhibits129: KemPharm Inc. – Product / Service
Exhibits130: KemPharm Inc. – Key offerings
Exhibits131: Merck and Co. Inc. – Overview
Exhibits132: Merck and Co. Inc. – Business segments
Exhibits133: Merck and Co. Inc. – Key news
Exhibits134: Merck and Co. Inc. – Key offerings
Exhibits135: Merck and Co. Inc. – Segment focus
Exhibits136: Novartis AG – Overview
Exhibits137: Novartis AG – Business segments
Exhibits138: Novartis AG – Key offerings
Exhibits139: Novartis AG – Segment focus
Exhibits140: Pfizer Inc. – Overview
Exhibits141: Pfizer Inc. – Product / Service
Exhibits142: Pfizer Inc. – Key news
Exhibits143: Pfizer Inc. – Key offerings
Exhibits144: Purdue Pharma LP – Overview
Exhibits145: Purdue Pharma LP – Product / Service
Exhibits146: Purdue Pharma LP – Key offerings
Exhibits147: Sanofi SA – Overview
Exhibits148: Sanofi SA – Business segments
Exhibits149: Sanofi SA – Key news
Exhibits150: Sanofi SA – Key offerings
Exhibits151: Sanofi SA – Segment focus
Exhibits152: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits153: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits154: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits155: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits156: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits157: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits158: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits159: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits161: Tris Pharma Inc. – Overview
Exhibits162: Tris Pharma Inc. – Product / Service
Exhibits163: Tris Pharma Inc. – Key offerings
Exhibits164: Viatris Inc. – Overview
Exhibits165: Viatris Inc. – Business segments
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations
